Literature DB >> 11812535

Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of D-amphetamine.

Alasdair M Barr1, Anthony G Phillips.   

Abstract

The exposure of humans and animals to high doses of psychostimulant drugs, followed by their withdrawal, leads to a number of aversive psychological symptoms. These symptoms include increased anxiety and anhedonia, and may be manifested behaviorally as a decreased interest in normally rewarding stimuli. In the present study, we determine the effects of withdrawal from an escalating-dose schedule of D-amphetamine on the consumption of a 4% sucrose solution under normal conditions, and after an incentive downshift. The downshift was induced by subjecting animals to a consumatory negative contrast paradigm, by switching them from a familiar 32% sucrose solution to a novel 4% solution. In unshifted animals, there was no effect of D-amphetamine withdrawal on consumption of the 4% solution. In contrast, drug-withdrawn animals displayed an exaggerated negative contrast effect, primarily reflected as a delayed recovery from the downshift lasting for at least 60 h. This effect is interpreted as a consequence of the increased emotionality of withdrawn animals, and may be related to disruption of normal search behaviors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812535     DOI: 10.1016/s0091-3057(01)00664-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

Review 1.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 2.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

3.  Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.

Authors:  D Peleg-Raibstein; E Sydekum; H Russig; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

4.  Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

Review 5.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

6.  Anticipation: An Essential Feature of Anhedonia.

Authors:  Anthony G Phillips; Soyon Ahn
Journal:  Curr Top Behav Neurosci       Date:  2022

7.  Sensitivity to reward loss as an indicator of animal emotion and welfare.

Authors:  Oliver H P Burman; Richard M A Parker; Elizabeth S Paul; Michael Mendl
Journal:  Biol Lett       Date:  2008-08-23       Impact factor: 3.703

Review 8.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

9.  Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact.

Authors:  Daria Peleg-Raibstein; Esther Sydekum; Holger Russig; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

Review 10.  Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Athina Markou
Journal:  Eur Neuropsychopharmacol       Date:  2013-10-14       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.